A closer look at the technologies used by Micreos
See more technologies
Micreos
Business Services · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Neuhofstrasse 12, Baar, Zug, 6340, Switz...Phone Number
+31 888007100Website
www.micreos.comRevenue
$15.8 MillionIndustry
About Micreos
Micreos is a biotech company based in Zug, Switzerland, focused on the discovery and development of recombinant proteins for chronic dermatology conditions, particularly Atopic Dermatitis. Their innovative engineered endolysin technology effectively eliminates harmful pathogens like Staphylococcus aureus, which exacerbates skin conditions, while preserving the skin's natural microbiome. With a commitment to addressing significant unmet medical needs, Micreos aims to enter clinical trials for their lead molecule, MEndoB, in late 2026. The company seeks collaboration with partners who share their vision of revolutionizing dermatological treatments.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Micreos Tech Stack
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Micreos
Sign Up For FreeTo access detailed company insights
Micreos is a biotech company based in Zug, Switzerland, focused on the discovery and development of recombinant proteins for chronic dermatology conditions, particularly Atopic Dermatitis. Their innovative engineered endolysin technology effectively eliminates harmful pathogens like Staphylococcus aureus, which exacerbates skin conditions, while pr... Read More
